Predictors of blood pressure response in the SYMPLICITY HTN-3 trial
David E. Kandzari(Piedmont Atlanta Hospital), George L. Bakris(University of Chicago), Laura P. Svetkey(Duke University), Joseph M. Massaro(Baim Institute for Clinical Research), Deepak L. Bhatt(Brigham and Women's Hospital), Murray Esler(Baker Heart and Diabetes Institute), Manesh R. Patel(Clinical Research Institute), David P. Lee, Krishna J. Rocha‐Singh(St. John's Hospital), Raymond R. Townsend(University of Pennsylvania), Martin Fahy(Medtronic (United States)), Janice P. Lea, Barry T. Katzen(Baptist Hospital of Miami), Laura Mauri(Brigham and Women's Hospital), Paul A. Sobotka, Chandan Devireddy, Sandeep Brar(Medtronic (United States)), Martin B. Leon(NewYork–Presbyterian Hospital), Adrian Ma(Stanford Health Care), William W. O’Neill, John M Flack(Wayne State University), Suzanne Oparil(University of Alabama at Birmingham)
Cited by 540
Related Papers
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
|Hypertension|2003|13.3k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
General Cardiovascular Risk Profile for Use in Primary Care
|Circulation|2008|7.4k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k